The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients
Open accessAbstract
BACKGROUND: Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An elevated PLR has been associated with poor prognosis in patients with different oncologic disorder. As platelets play a key role in atherosclerosis and atherothrombosis, we investigated PLR and its association with critical limb ischemia (CLI) and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. METHODS AND FINDINGS: We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. PLR was calculated and the cohort was categorized into tertiles according to the PLR. An optimal cut-off value for the continuous PLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in PLR. As an optimal cut-off value, a PLR of 150 was identified. Two groups were categorized, one containing 1228 patients (PLR≤150) and a second group with 893 patients (PLR>150). CLI was more frequent in PLR>150 patients (410(45.9%)) compared to PLR≤150 patients (270(22.0%)) (p<0.001), as was prior myocardial infarction (51(5.7%) vs. 42(3.5%), p = 0.02). Regarding inflammatory parameters, C-reactive protein (median 7.0 mg/l (3.0-24.25) vs. median 5.0 mg/l (2.0-10.0)) and fibrinogen (median 457 mg/dl (359.0-583.0) vs. 372 mg/dl (317.25-455.75)) also significantly differed in the two patient groups (both p<0.001). Finally, a PLR>150 was associated with an OR of 1.9 (95%CI 1.7-2.1) for CLI even after adjustment for other well-established vascular risk factors. CONCLUSIONS: An increased PLR is significantly associated with patients at high risk for CLI and other cardiovascular endpoints. The PLR is a broadly available and cheap marker, which could be used to highlight patients at high risk for vascular endpoints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Platelets in inflammation and atherogenesis
Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,468
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.009 · Cited by 1,021
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005
Tamhane, U. U., Aneja, S., Montgomery, D., Rogers, E.-K., Eagle, K. A., & Gurm, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.006 · Cited by 900
Kwon, H.-C., Kim, S. H., Oh, S. Y., Lee, S., Lee, J. H., Choi, H.-J., Park, K.-J., Roh, M. S., Kim, S.-G., Kim, H.-J., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.656705 · Cited by 409
Atrial Fibrillation and Death After Myocardial Infarction: A Community Study
Jabre, P., Jouven, X., Adnet, F., Thabut, G., Bielinski, S. J., Weston, S. A., & Roger, V. L. (2011) · Circulation · doi:10.1161/circulationaha.110.990192 · Cited by 255
Platelets, inflammation and atherosclerosis
LINDEMANN, S., KRÄMER, B., SEIZER, P., & GAWAZ, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02517.x · Cited by 244
Suades, R., Padró, T., Vilahur, G., & Badimon, L. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0486 · Cited by 195
Cited by
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases
Gasparyan, A. Y., Ayvazyan, L., Mukanova, U., Yessirkepov, M., & Kitas, G. D. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.4.345 · Cited by 607
Candemir, M., Kiziltunç, E., Nurkoç, S., & Şahinarslan, A. (2021) · Angiology · doi:10.1177/0003319720987743 · Cited by 181
The association between platelet/lymphocyte ratio and coronary artery disease severity
Yuksel, M., Yildiz, A., Oylumlu, M., Akyuz, A., Aydin, M., Kaya, H., Acet, H., Polat, N., Bilik, M. Z., & Alan, S. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5565 · Cited by 127
Li, H., Zhou, Y., Ma, Y., Han, S., & Zhou, L. (2017) · Kardiologia Polska · doi:10.5603/kp.a2017.0068 · Cited by 90
Zhou, D., Wang, G., Fan, Y., Wan, Z., & Liu, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3993 · Cited by 40
Metadata
- Authors
- Gary, T., Pichler, M., Belaj, K., Hafner, F., Gerger, A., Froehlich, H., Eller, P., Rief, P., Hackl, G., Pilger, E., & Brodmann, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-02
- Volume
- 8
- Issue
- 7
- Pages
- e67688
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1979663568
- Cited by
- 296
- References
- 17
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients. https://app.cochat.ai/papers/10.1371/journal.pone.0067688
- The paper
- Gary, T., Pichler, M., Belaj, K., Hafner, F., Gerger, A., Froehlich, H., Eller, P., Rief, P., Hackl, G., Pilger, E., & Brodmann, M. (2013). Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0067688
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.